Company

Rimidi Diabetes Inc.

Rimidi Diabetes Inc. provides a software platform for chronic disease management and remote patient monitoring, mainly for type 2 diabetes.

About

Founded in 2012 and headquartered in Atlanta, US, Rimidi sells a subscription software platform to healthcare providers that works with existing electronic health records to run remote patient monitoring programs. Lucienne Ide co-founded the company. In July 2018 Rimidi raised USD 6.58 mn in Series A funding from investors including Eli Lilly & Company and Turner Investments.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in